**Core tip:** The Kyoto classification organizes endoscopic findings based on *Helicobacter pylori (H. pylori)* infection. The score of the Kyoto classification is the sum of scores of five endoscopic findings (atrophy, intestinal metaplasia, enlarged folds, nodularity, and diffuse redness with or without regular arrangement of collecting venules) and ranges from 0 to 8. A high score is believed to reflect a higher risk of current *H. pylori* infection and gastric cancer. A Kyoto classification score of 0 indicates no *H. pylori* infection. A Kyoto classification score of ≥ 2 indicates current *H. pylori* infection. A Kyoto classification score of ≥ 4 might indicate gastric cancer risk.

INTRODUCTION
============

Gastric cancer is the third most common cancer in the world and is the cancer with the third greatest number of mortalities. If gastric cancer is detected at an early stage, it can be cured via endoscopic submucosal dissection\[[@B1],[@B2]\]. Although periodic endoscopic examination is important for detecting early gastric cancer, efficient surveillance requires identification of high-risk populations\[[@B3]-[@B7]\]. The genetic risks of gastric cancer have been reported to include hereditary cancer syndrome, single nucleotide polymorphisms, and family history\[[@B8]-[@B12]\]. Environmental risks include *Helicobacter pylori* infection, smoking, excessive salt consumption, and lack of vegetable. Among them, the association between *H. pylori* infection and the development of gastric cancer is well established, and *H. pylori* virulence factors (cagA, vacA, iceA, and dupA) are known\[[@B13]-[@B16]\]. The International Agency for Research on Cancer categorized *H. pylori* infection as a type I carcinogen and it is considered the primary cause of gastric cancer. On the other hand, *H. pylori* eradication reduces gastric cancer risk\[[@B17]-[@B20]\]. Therefore, the accurate assessment of *H. pylori* infection status is important. Nowadays, endoscopic examination is required to diagnose *H. pylori* infection status. In 2013, the Japan Gastroenterological Endoscopy Society advocated the Kyoto classification, a new grading system for endoscopic gastritis. In this review, we focus on up-to-date reports regarding the Kyoto classification to help improve endoscopic practice.

DEFINITION OF KYOTO CLASSIFICATION OF GASTRITIS
===============================================

Thanks to advances in endoscopic technology, it is now possible to observe the gastric mucosa in minute detail. Today, endoscopy is used in the diagnosis of gastritis to determine the presence/absence of *H. pylori* infection and evaluate the risks of gastric cancer. The Kyoto classification of endoscopic findings was advocated when the 85^th^ Congress of the Japan Gastroenterological Endoscopy Society was held in Kyoto in 2013. The purpose of the Kyoto classification was to evaluate the gastric mucosa, as this presents a potential risk of developing gastric cancer\[[@B21],[@B22]\]. In this classification, 19 endoscopic findings related to gastritis, including atrophy, intestinal metaplasia, enlarged folds (tortuous folds), nodularity, diffuse redness, regular arrangement of collecting venules (RAC), map-like redness, foveolar-hyperplastic polyp, xanthoma, mucosal swelling, patchy redness, depressed erosion, sticky mucus, hematin, red streak, spotty redness, multiple white and flat elevated lesions, fundic gland polyp, and raised erosion, are characterized. Among them, atrophy, intestinal metaplasia, enlarged folds, and nodularity, which may be related to gastric cancer risk, and diffuse redness with or without RAC, which is related to *H. pylori* infection status, are accounted for in the Kyoto classification score (Table [1](#T1){ref-type="table"})\[[@B22]\].

###### 

Kyoto classification score

  **Kyoto classification**   **Score**
  -------------------------- -----------
  Atrophy                    
    None, C1                 0
    C2 and C3                1
    O1-O3                    2
  Intestinal metaplasia      
    None                     0
    Antrum                   1
    Corpus and antrum        2
  Enlarged folds             
    Absence                  0
    Presence                 1
  Nodularity                 
    Absence                  0
    Presence                 1
  Diffuse redness            
    None                     0
    Mild (with RAC)          1
    Severe                   2
  Kyoto score                0-8

RAC: Regular arrangement of collecting venules.

Endoscopic atrophy (Kimura-Takemoto classification)
---------------------------------------------------

Atrophy includes "pathological" atrophy and "endoscopic" atrophy. Atrophy is pathologically defined as a loss of glandular tissue\[[@B23]\]. The Kyoto classification adopted Kimura-Takemoto classification of endoscopic atrophy\[[@B24]\]. Kimura et al\[[@B24]\] defined a visible capillary network, low niveau, and yellowish pale in color as atrophic features, while diffuse redness with high mucosal height as characteristics of non-atrophy. We show endoscopic images and a schematic diagram in Figure [1](#F1){ref-type="fig"}. "Endoscopic" atrophy has been reported to correlate well with "pathological" atrophy\[[@B25]-[@B29]\]. In the Kyoto classification score, non-atrophy (C0) and C1 were scored as Atrophy score 0, C2 and C3 as Atrophy score 1, and O1 to O3 as Atrophy score 2.

![Kimura-Takemoto classification of endoscopic atrophy. Atrophic borders are indicated by a dotted line. A: C1 (Atrophy is limited to the antrum); B: C2 (Atrophy is limited to the minor area of the lesser curvature of the body); C: C3 (Atrophy exists in the major area of the lesser curvature of the body but does not extend beyond the cardia); D: O1 (Atrophy extends to the fundus over the cardia. Atrophic border of the body lies between the lesser curvature and anterior wall); E: O2 (Atrophic border of the body lies on the anterior wall); F: O3 (Atrophy is widespread with the border between the anterior wall and greater curvature).](WJG-26-466-g001){#F1}

Endoscopic intestinal metaplasia
--------------------------------

Intestinal metaplasia typically appears grayish-white and slightly elevated plaques surrounded by mixed patchy pink and pale areas of mucosa, forming an irregular uneven surface (Figure [2A](#F2){ref-type="fig"}). A villous appearance, whitish mucosa, and rough mucosal surface are useful indicators for endoscopic diagnosis of intestinal metaplasia\[[@B30]\]. Image-enhanced endoscopy, including narrow-band imaging (NBI), blue laser imaging, and linked color imaging, has improved the visibility of endoscopic findings and accuracy of endoscopic diagnosis of intestinal metaplasia\[[@B31]-[@B39]\]. A white opaque substance on the surface epithelium and light blue crest on the mucosal epithelial rim visualized using magnified NBI are associated with intestinal metaplasia\[[@B40]-[@B42]\].

![Endoscopic findings of Kyoto classification. A: Intestinal metaplasia; B: Map-like redness; C: Enlarged folds; D: Nodularity; E: Diffuse redness; F: Regular arrangement of collecting venules in weakly magnified image.](WJG-26-466-g002){#F2}

In the Kyoto classification score, the absence of intestinal metaplasia was scored as Intestinal metaplasia score 0, the presence of intestinal metaplasia within the antrum as Intestinal metaplasia score 1, and intestinal metaplasia extending into the corpus as Intestinal metaplasia score 2. The Intestinal metaplasia score is diagnosed by using white light imaging. Intestinal metaplasia diagnosis based on image-enhanced endoscopy using NBI, blue laser imaging, linked color imaging, and chromo-endoscopy is not included in the Kyoto score.

Map-like redness (synonymous with mottled patchy erythema) is defined as multiple flat or slightly depressed erythematous lesions that have various shapes, sizes, and red densities (Figure [2B](#F2){ref-type="fig"})\[[@B6],[@B43]\]. When using biopsy specimens of map-like redness, intestinal metaplasia is frequently observed (87.3%)\[[@B43]\]. The mechanism of the appearance of map-like redness is thought to be strengthening of the contrast between non-atrophic mucosa and atrophic mucosa after diffuse redness has disappeared following successful eradication\[[@B21]\]. Map-like redness is not always found following eradication. However, when it is observed, there is virtually no doubt that it is indicative of post-eradication gastric mucosa\[[@B22]\].

Enlarged folds
--------------

An enlarged fold is defined as a fold with a width of 5 mm or more that is not flattened or is only partially flattened by insufflation of the stomach (Figure [2C](#F2){ref-type="fig"}). Rugal hyperplasia is a synonym for enlarged folds.

In the Kyoto classification score, the absence and presence of enlarged folds was scored as Enlarged folds score 0 and 1, respectively.

Nodularity
----------

Nodular gastritis is characterized by a miliary pattern resembling "goose flesh" mainly located in the antrum (Figure [2D](#F2){ref-type="fig"}). Nodularity can be more clearly seen following the use of indigo carmine spray. Lymphoid follicles and/or intense inflammatory cell infiltration are observed in biopsy specimens of nodularity\[[@B44]\]. Nodular gastritis displays a female predominance and improves gradually with age. A high serum *H. pylori* antibody titer is correlated to nodularity\[[@B45]-[@B49]\].

In the Kyoto classification score, the absence and presence of nodularity was scored as Nodularity score 0 and 1, respectively.

Diffuse redness
---------------

Diffuse redness refers to uniform redness with continuous expansion observed in non-atrophic mucosa mainly in the corpus (Figure [2E](#F2){ref-type="fig"}) and is typical of endoscopic superficial gastritis\[[@B22],[@B24]\]. Congestion and dilation of the subepithelial capillary network in the gastric mucosa with inflammatory change of the mucosal surface color to red\[[@B50]\]. Since the assessment of the severity of diffuse redness is affected by the setting of the endoscope and monitor, objective assessment may be difficult.

On the other hand, RAC is a condition in which the collecting venules are arranged in the corpus. From a distance, it appears like numerous dots. From up close, it has the appearance of a regular pattern of starfish-like shapes (Figure [2F](#F2){ref-type="fig"}).

In the Kyoto classification score, the absence of diffuse redness was scored as Diffuse redness score 0, mild diffuse redness or diffuse redness with RAC as Diffuse redness score 1, and severe diffuse redness or diffuse redness without RAC as Diffuse redness score 2.

Kyoto classification score
--------------------------

The Kyoto classification score for gastritis is based on the sum of scores of the five endoscopic findings and ranges from 0 to 8 (Table [1](#T1){ref-type="table"}). A high score is believed to reflect increased risk of *H. pylori* infection and gastric cancer. In a study that evaluated the usefulness and convenience of the Kyoto classification, a mini-lecture improved the accuracy of endoscopic diagnosis\[[@B51]\].

DIAGNOSIS OF *HELICOBACTER PYLORI* INFECTION BY ENDOSCOPIC FINDINGS
===================================================================

There are several reports to investigate the relationship between endoscopic findings and *H. pylori* infection\[[@B52]-[@B56]\]. Table [2](#T2){ref-type="table"} shows the diagnostic values of the Kyoto classification for *H. pylori* infection\[[@B57]-[@B62]\]. Enlarged folds had a relatively good positive predictive value (56.2--86.0%). Although nodularity had a low sensitivity (6.4%--32.1%) for *H. pylori* infection, it had excellent specificity for a current infection (95.8%--98.8%). Diffuse redness had a good positive predictive value (65.6%--91.5%). RAC had a high sensitivity for non-infection (86.7%--100%).

###### 

Diagnostic value of Kyoto classification for *Helicobacter pylori* infection

  **Endoscopic findings**                        **Ref**.                       **Year**   **No. of subjects**   **Sensitivity**   **Specificity**   **PPV**   **NPV**
  ---------------------------------------------- ------------------------------ ---------- --------------------- ----------------- ----------------- --------- ---------
  Diagnosis for current *H. pylori* infection                                                                                                                  
  Enlarged folds                                 Kato et al\[[@B59]\]           2013       275                   58.5              79.5              76.9      62.2
  Enlarged folds                                 Mao et al\[[@B60]\]            2016       256                   60.2              92.3              86.0      74.6
  Enlarged folds                                 Yoshii et al\[[@B61]\]         2019       498                   23.1              96.6              56.2      87.0
  Nodularity                                     Laine et al\[[@B57]\]          1995       52                    32.1              95.8              90.0      54.8
  Nodularity                                     Kato et al\[[@B59]\]           2013       275                   5.3               98.8              75.0      59.4
  Nodularity                                     Yoshii et al\[[@B61]\]         2019       498                   6.4               98.3              41.7      84.9
  Diffuse redness                                Kato et al\[[@B59]\]           2013       275                   83.4              66.9              73.8      78.4
  Diffuse redness                                Mao et al\[[@B60]\]            2016       256                   57.5              95.8              91.5      74.7
  Diffuse redness                                Yoshii et al\[[@B61]\]         2019       498                   60.0              94.7              65.6      93.3
  Diagnosis for negative *H. pylori* infection                                                                                                                 
  RAC                                            Yagi et al\[[@B58]\]           2002       557                   91.1              97.9              95.0      96.2
  RAC                                            Kato et al\[[@B59]\]           2013       275                   93.6              48.0              87.0      66.8
  RAC                                            Mao et al\[[@B60]\]            2016       256                   86.7              90.2              87.5      89.6
  RAC                                            Garcés-Durán et al\[[@B62]\]   2019       140                   100.0             49.0              47.3      100.0

PPV: Positive predictive value; NPV: Negative predictive value; RAC: Regular arrangement of collecting venules; *H. pylori*: *Helicobacter pylori*.

Yoshii et al\[[@B61]\] reported that endoscopic atrophy has a specificity of 75.5% for the diagnosis of past *H. pylori* infection. Furthermore, intestinal metaplasia and map-like redness also have a higher specificity (92.6% and 98.0%, respectively) for the diagnosis of past *H. pylori* infection.

Diagnosis of H. pylori infection based on Kyoto classification score
--------------------------------------------------------------------

Several studies investigated the relationship between the total Kyoto classification score and *H. pylori* infection. We reported an association between total Kyoto classification score and serum *H. pylori* antibody titer\[[@B48]\]. Kyoto scores were 0.1, 0.4, 1.9, and 2.3 for negative-low, negative-high, positive-low, and positive-high titers of *H. pylori* antibody, respectively. Kyoto scores increased in line with the *H. pylori* antibody titer. In subjects with a negative-high *H. pylori* antibody titer, the Kyoto classification had an excellent area under the receiver operating characteristics curve (0.886) for predicting *H. pylori* infection with a cutoff value of 2. A Kyoto score of ≥ 2 could predict *H. pylori* infection with an accuracy of 90%\[[@B63]\]. In 870 subjects with no history of *H. pylori* eradication therapy, *H. pylori* infection rates in those with Kyoto classification scores of 0, 1, and ≥ 2 were 1.5%, 45%, and 82%, respectively\[[@B64]\].

High Kyoto scores do not always correspond to an active *H. pylori* infection. False diagnosis can occur due to either a spontaneous negative conversion or an unintentional eradication. In cases of spontaneous negative conversion, the harsh environment of the intestinal metaplasia removes the *H. pylori* infection spontaneously. In cases of unintentional eradication, the *H. pylori* infection is eradicated after the treatment of other infectious diseases with antibiotics.

Essentially, a Kyoto classification score of ≥ 2 indicates *H. pylori* infection. On the other hand, a Kyoto classification score of 0 indicates no *H. pylori* infection.

GASTRIC CANCER RISK ASSESSED BASED ON ENDOSCOPIC FINDINGS OF KYOTO CLASSIFICATION
=================================================================================

There are several reports of gastric cancer risk assessed based on endoscopic findings\[[@B65]-[@B69]\]. Three Japanese cohort studies revealed the association of endoscopic atrophy with gastric cancer incidence (Table [3](#T3){ref-type="table"}). They showed that the gastric cancer incidence of mild, moderate, and severe atrophy is 0.04%--0.10%/year, 0.12%--0.34%/year, and 0.31%--1.60%/year, respectively\[[@B70]-[@B72]\]. Shichijo et al\[[@B71]\] reported that cancer incidence was extremely high, affecting 16.0% of patients with severe atrophy over 10-year periods. Gastric cancer risk increases according to the extent of the gastric atrophy.

###### 

Gastric cancer incidence according to endoscopic atrophy

  **Ref**.                         **Population**                       **No. of subjects**   **No. of cancers**   **Duration, yr**   **Gastric cancer incidence, %/yr**                                            
  -------------------------------- ------------------------------------ --------------------- -------------------- ------------------ -------------------------------------- -------------------------------------- --------------------------------------
  Take et al\[[@B70]\], 2011       Post eradication with peptic ulcer   1674                  28                   5.6                0.04                                   0.28                                   0.62
  Shichijo et al\[[@B71]\], 2016   Post eradication                     573                   21                   6.2                0.07[1](#T3FN1){ref-type="table-fn"}   0.34[1](#T3FN1){ref-type="table-fn"}   1.60[1](#T3FN1){ref-type="table-fn"}
  Kaji et al\[[@B72]\], 2019       Medical examination                  12941                 63                   3.7                0.10                                   0.16                                   0.31
                                   Post eradication                     2571                  20                   3.7                0.06                                   0.12                                   0.42

Incidence was calculated by dividing the incidence per 10 years by 10.

Table [4](#T4){ref-type="table"} shows the odds ratio of gastric cancer depending on the presence or absence of the endoscopic findings of the Kyoto classification\[[@B49],[@B73]-[@B75]\]. Gastric atrophy (open-type) was associated with gastric cancer with an odds ratio of 7.2--14.2\[[@B76],[@B77]\].

###### 

Odds ratios of endoscopic findings for gastric cancer

  **Endoscopic findings**   **Ref**.                             **Population**         **No. of subjects**   **Odds ratio**
  ------------------------- ------------------------------------ ---------------------- --------------------- --------------------------------------
  Atrophy                   Masuyama et al\[[@B76]\], 2015       Without eradication    27777                 14.2[1](#T4FN1){ref-type="table-fn"}
  Atrophy                   Sekikawa et al\[[@B77]\], 2016       Screening              1823                  7.2[1](#T4FN1){ref-type="table-fn"}
  Intestinal metaplasia     Sugimoto et al\[[@B74]\], 2017       Endoscopic gastritis   1200                  5.0
  Enlarged folds            Nishibayashi et al\[[@B73]\], 2003   *H. pylori* positive   276                   5.0
  Nodularity                Nishikawa et al\[[@B49]\], 2018      *H. pylori* positive   674                   13.9
  RAC                       Majima et al\[[@B75]\], 2019         Post eradication       194                   0.4

Odds ratio for open-type atrophy calculated with closed-type atrophy as a reference. RAC: Regular arrangement of collecting venules; *H. pylori*: *Helicobacter pylori*.

Sugimoto et al\[[@B74]\] have reported that endoscopic intestinal metaplasia was associated with early gastric cancer with an odds ratio of 5.0. Intestinal metaplasia is reported to be associated with intestinal-type cancer\[[@B78]\].

A cross-sectional study reported an odds ratio of 5.0 for enlarged folds of 5 mm or more for gastric cancer patient with *H. pylori*-infected controls as a reference\[[@B73]\]. It also indicated an upward shift in the distribution of gastric fold widths in *H. pylori-*positive patients with gastric cancer to an odds ratio of 35.5 in those with a fold width of 7 mm. Inflammation-induced DNA methylation of various genes is involved in the development of gastric cancer in gastritis with enlarged folds\[[@B50],[@B73],[@B79]-[@B85]\]. Enlarged folds are reported to be associated with diffuse-type gastric cancer\[[@B73],[@B86]\].

Nishikawa et al\[[@B49]\] reported an odds ratio of 13.9 for gastric cancer in *H. pylori*-positive patients with nodularity. In a study involving *H. pylori*-positive patients under the age of 29, nodularity provided an odds ratio of 64.2 for gastric cancer. Nodularity is reported to be associated with diffuse-type cancer\[[@B49],[@B87]\].

RAC was reported to be negatively associated with gastric cancer (odds ratio: 0.4)\[[@B75]\].

Gastric cancer risk assessed using the Kyoto classification score
-----------------------------------------------------------------

Sugimoto et al\[[@B74]\] presented the relationship between total Kyoto classification score and gastric cancer risk. In their cross-sectional study, the total Kyoto classifications scores of patients with and without gastric cancer were 4.8 and 3.8, respectively. This study suggests that a Kyoto classification score of ≥ 4 might indicate gastric cancer risk.

CONCLUSION
==========

The Kyoto classification organized endoscopic findings related to *H. pylori* infection. A Kyoto classification score ≥ 2 indicates *H. pylori* infection. An *H. pylori* test is essential for such cases with no history of *H. pylori* eradication.

A Kyoto classification score ≥ 4 might indicate gastric cancer risk. Such cases need careful follow-up. However, research related to the Kyoto score is still scarce and further study is needed.
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